Searle & Co.
- SEC CIK
- 0000710127
- Latest filing
- Jul 27, 2026
AZN holding history
AstraZeneca PLC in every 13F filed by Searle & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AZN overviewAll 13F holders of AZNFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 21
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −17,675−100.0% | Sold out | Holders |
| Q1 2026 | 17,675 | $3.42M | 0.9% | 00.0% | UnchangedConverted for a 1-for-2 split | Holders |
| Q4 2025 | 35,350 | $3.25M | 0.8% | 00.0% | Unchanged | Holders |
| Q3 2025 | 35,350 | $2.71M | 0.7% | 00.0% | Unchanged | Holders |
| Q2 2025 | 35,350 | $2.47M | 0.7% | 00.0% | Unchanged | Holders |
| Q1 2025 | 35,350 | $2.60M | 0.7% | 00.0% | Unchanged | Holders |
| Q4 2024 | 35,350 | $2.32M | 0.7% | 00.0% | Unchanged | Holders |
| Q3 2024 | 35,350 | $2.75M | 0.7% | 00.0% | Unchanged | Holders |
| Q2 2024 | 35,350 | $2.76M | 0.6% | 00.0% | Unchanged | Holders |
| Q1 2024 | 35,350 | $2.39M | 0.6% | 00.0% | Unchanged | Holders |
| Q4 2023 | 35,350 | $2.38M | 0.7% | 00.0% | Unchanged | Holders |
| Q3 2023 | 35,350 | $2.39M | 0.8% | 00.0% | Unchanged | Holders |
| Q2 2023 | 35,350 | $2.53M | 0.8% | 00.0% | Unchanged | Holders |
| Q1 2023 | 35,350 | $2.59M | 0.8% | 00.0% | Unchanged | Holders |
| Q4 2022 | 35,350 | $2.40M | 0.8% | 00.0% | Unchanged | Holders |
| Q3 2022 | 35,350 | $1.94M | 0.7% | 00.0% | Unchanged | Holders |
| Q2 2022 | 35,350 | $2.34M | 0.9% | −250−0.7% | Reduced | Holders |
| Q1 2022 | 35,600 | $2.36M | 0.9% | 00.0% | Unchanged | Holders |
| Q4 2021 | 35,600 | $2.07M | 0.8% | 00.0% | Unchanged | Holders |
| Q3 2021 | 35,600 | $2.14M | 0.9% | 00.0% | Unchanged | Holders |
| Q2 2021 | 35,600 | $2.13M | 0.9% | 00.0% | Unchanged | Holders |
| Q1 2021 | 35,600 | $1.77M | 0.8% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.